DB Software Musings

This is Not a Doximity Short Report

DB
Aug 23, 2025
∙ Paid
2
6
Share

As much as I think DOCS is severely valued, the reality is that pharmaceutical marketing is a large market, whether you believe the ROI or not. DOCS has two key business: the dialer and a marketing business geared towards the life sciences market. Pharmaceutical manufacturers and hospital systems can pay to promote content on the Doximity platform. This…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Software Musings
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture